| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/22/2005 | EP1542668A2 Aripiprazole complex formulation and method |
| 06/22/2005 | EP1542666A1 Modafinil pharmaceutical compositions |
| 06/22/2005 | EP1542657A1 Cannabinoid liquid formulations for mucosal amdinistration |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1411879A4 A composition and uses therefor for combating hangover |
| 06/22/2005 | EP1383752B1 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1233964B1 New use and novel n-azabicyclo-amide derivatives |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1173160B1 (e)-styryl sulfone anticancer agents |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | EP0932416B1 Method and potentiated composition for treating migraine |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630713A Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 06/22/2005 | CN1630710A Compositions including ammonia oxidizing bacteria and methods of using same |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630656A Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 06/22/2005 | CN1630652A New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds |
| 06/22/2005 | CN1630651A Novel gamma secretase inhibitors |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630645A 5-HT receptor ligands and uses thereof |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1630638A Aryl ureas as kinase inhibitors |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630631A Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630528A Brain cell or nerve cell protecting agents comprising ginseng |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630514A Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | CN1630512A Pharmaceutical tablet |
| 06/22/2005 | CN1630511A Particulate compositions of eletriptan showing a sigmoidal pattern of controlled release |
| 06/22/2005 | CN1629156A Pyrudyl and pyrimidylpiperazine derivatives, preparation method thereof and pharmaceutical composition containing the derivatives |
| 06/22/2005 | CN1629153A 西酞普兰中间体晶体碱 Citalopram intermediate crystal base |
| 06/22/2005 | CN1628819A Scorpion and Chinese goldthread containing pills for drug abstinence |
| 06/22/2005 | CN1628806A Insomnia treating medicinal wine |
| 06/22/2005 | CN1628783A Oral liquor containing creeping oxalis, zedoary and dahurian angelica and its preparing method |
| 06/22/2005 | CN1628781A Medicine for treating Parkinson's disease |
| 06/22/2005 | CN1628777A Application of epimedium extractive in the preparation of medicine for preventing and treating depression |
| 06/22/2005 | CN1628766A Formulation of 'Xuefu Zhuyu Decoction' and its preparation method |
| 06/22/2005 | CN1628742A Healthy nutrient product for tranquilizing mind |
| 06/22/2005 | CN1628740A Long acting, pain stopping liquor and its preparation process |
| 06/22/2005 | CN1628731A Chinese medicinal composition for drug abstinence |
| 06/22/2005 | CN1628708A Administering method of a botanical essential oil |
| 06/22/2005 | CN1628702A Method for preparing sleep assisting melatonin milk tablet |
| 06/22/2005 | CN1628694A The second purpose of Siberian solomonseal rhizome polysaccharide |
| 06/22/2005 | CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof |
| 06/22/2005 | CN1628692A Antidepressant Chinese traditional medicine and its purposes |
| 06/22/2005 | CN1628690A Citicoline slow controlled release preparation and preparing method thereof |
| 06/22/2005 | CN1628680A Medicine preparation for treating senile dementia |
| 06/22/2005 | CN1628674A Lingustrazine Phosphate soft capsule and preparation method thereof |
| 06/22/2005 | CN1628673A 胞磷胆碱分散片及其制备方法 Citicoline tablet and its preparation method |
| 06/22/2005 | CN1628670A Medicine combination of amino acid zinc salt and antidepressant and medical purposes |
| 06/22/2005 | CN1628668A Lomerizine hydrochloride orally disintegrating tablet and preparation method thereof |
| 06/22/2005 | CN1628662A Medicine with abirritation |
| 06/22/2005 | CN1628651A Alcohol effect relieving refreshment liver protecting preparation |
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207042C Insomnia treating medicine and its preparation |
| 06/22/2005 | CN1207039C Medicine for treating cerebral concussion and injuries from falls |
| 06/22/2005 | CN1207005C Rabbit skin containing bioactive substance and its use |
| 06/22/2005 | CN1206994C Medicinal complsition containing vitamin B 1, preparation process and use thereof |
| 06/22/2005 | CN1206993C Buspirong hydrochloride transdemal absorption preparation |
| 06/22/2005 | CN1206989C Mixed snuff prepn. for reducing side effect of Apomorphinum |
| 06/22/2005 | CN1206983C Coated Hypericum perforatus extract micro pill preparation and its preparing process |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6908944 Using 1-phenyl-4-(dimethylaminomethyl)cyclohexane |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908929 Central nervous system disorders |
| 06/21/2005 | US6908927 Reduction physical cigarette smoking |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | US6908914 Antipsychotic cyclic N-aralkylamines |
| 06/21/2005 | US6908902 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 06/21/2005 | US6908900 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 06/21/2005 | US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay |
| 06/21/2005 | US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 06/21/2005 | US6908611 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 06/21/2005 | CA2359541C Anticonvulsant derivatives useful in treating cluster headaches |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |